In this Sounding Board, the author examines potential reasons for the limited availability of new drugs and proposes four solutions to this problem.
No takes yet. Share an insight, caveat, or question.
Alastair J.J. Wood (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: